Sunday, 17 November 2019

Airway Management Devices Market to Reflect a Holistic Expansion During the Forecast Period

The global airway management devices market is expected to reach USD 2.1 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of chronic respiratory diseases is a high impact rendering growth driver for this market. This increasing prevalence is presumed to be driving the clinical urgency to adopt airway management devices in order to improve the existing ventilation solutions and prevent conditions such as laryngospasms as well as reduce long-term cost associated with the conventional methods.

In addition, advent of new-generation devices that incorporate a wide array of fiber optic, optical, video, and mechanical technologies to facilitate better view of and help management of difficult airways are gaining popularity. For instance, video laryngoscopes, which allow real-time and enhanced visualization, are rapidly becoming first-line measure in emergency care for efficient difficult airway management in hospitals as well as outpatient settings. The benefits of consistent technological advancements include improved optics, better aspiration capabilities, battery-powered light sources, increased angulation capabilities, and improved reprocessing procedures. The aforementioned benefits are anticipated to present the market with lucrative growth opportunities during the forecast period.
Access Research Report of Airway Management Devices Market @ www.grandviewresearch.com/industry-analysis/airway-management-devices-market

Further key findings from the study suggest:
·       Supraglottic segment is expected to exhibit lucrative growth during the forecast period. The exponential growth can be attributed to increasing adoption of laryngeal masks in wide range of clinical applications, such as cardiopulmonary resuscitation and other medical emergencies
·       Emergency medicine is anticipated to exhibit lucrative CAGR during the forecast period owing to increasing significance of these devices in rapid sequence intubation
·       In 2016, North America held a dominant share of the global market as a consequence of local presence of prominent market players working toward extensive commercialization of their product portfolio
·       Asia Pacific is anticipated to grow at an exponential CAGR due to unmet patient needs, continuous technological & infrastructural upgradation, and increasing healthcare expenditure
·       The key participants such as Ambu A/S, Teleflex, Smiths Medical, Medtronic, Intersurgical, Armstrong Medical Limited and Becton Dickinson and Company are employing sustainability strategies to gain competitive advantage.
·       For instance, in September 2016, Ambu A/S completed the acquisition of ETView Medical Ltd., a medical device manufacturer. The acquisition was carried out to cater unmet patient needs and provide advanced products that allow continuous airway monitoring
Grand View Research has segmented the airway management devices market on the basis of product, application, end use, and region:
Airway Management Devices Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Supraglottic Devices
o    Oropharyngeal Devices
o    Nasopharyngeal Devices
o    Laryngeal Airway Masks
o    Others
·         Infraglottic Devices
o    Endotracheal Tubes
o    Tracheostomy Tubes
o    Others
·         Resuscitators
·         Laryngoscopes
·         Others
Airway Management Devices Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Anesthesia
·         Emergency Medicine
·         Others
Airway Management Devices End-Use Outlook (Revenue, USD Million, 2014 - 2025)
·         Hospitals
·         Homecare
·         Others
Airway Management Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
o    India
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Multiple Sclerosis Therapeutics Market to Reach Around $24.8 Billion by 2024

The global multiple sclerosis therapeutics market is expected to reach USD 24.8 billion by 2024 according to a new report by Grand View Research, Inc.

The presence of high unmet clinical needs in developing regions is one of the highest impact rendering drivers of the multiple sclerosis therapeutics market. Many organizations over the globe are actively involved in spreading awareness among people regarding progressive multiple sclerosis and the symptoms associated with it. Some notable examples include the National Multiple Sclerosis Society (NMSS) in the U.S., Multiple Sclerosis International Federation in Canada, European Multiple Sclerosis Platform (EMSP), and the Multiple Sclerosis Society (MSC).
Reimbursement programs are also anticipated to enhance the penetration of multiple sclerosis drugs. For instance, In June 2014, Biogen Idec Canada, announced that its TECFIDERA drug for the treatment of MS is available for reimbursement in British Colombia through B.C PharmaCare.
The introduction of novel therapeutics with minimal dosage requirement and cost-effectiveness is further expected to favor market growth. For, instance Lemtrada by Sanofi needs to be administered 3-5 times per year as compared to Copaxone, which requires daily administration.
To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/multiple-sclerosis-therapeutics-market

Further key findings from the study suggest:
·       The dominant drug class segment in 2015 was immunomodulators. Avonex, Betaseron, Copaxone, and Rebif were the key drugs capturing over 75% of market share in 2015.The introduction of Tecifedra, an oral immunomodulatory drug in 2015 has been a major breakthrough in this segment.
·       The declining revenue of Copaxone, Gilenya, Avonex, and Tysabri is forecasted by considering the factors such as limited usage rates of these drugs owing to the availability of highly potent FDA-approved oral drugs, Aubigio and Tecfidera
·       Immunosuppressant,on the other hand, is expected to witness significant growth of over 18.0%. The presence of a strong drug pipeline and its expected commercialization in the coming six years are some factors expected to drive market growth
·       In 2015, the injectable drugs market held the largest share owing to high prescription rates & price
·       North America dominated the overall multiple sclerosis therapeutics market with revenue estimates at over 13.0 billion in 2015. The increasing prevalence of multiple sclerosis, the introduction of new drugs, and high prices of drugs, such as Tysabri and Aubagio in the U.S., are some factors responsible for its dominance.
·       Major companies operating in this market are Biogen Idec, Teva Pharmaceuticals, Bayer Healthcare, Pfizer, Sanofi Aventis, Merck, Novartis, and AbbVie. Market players are upgrading the product portfolio by launching generic versions to sustain its market position. For instance, in 2015, Novartis launched a generic version of Copaxone named Glatopa in the U.S.
Grand View Research has segmented the multiple sclerosis therapeutics market on the basis of drug class, mode of administration, and region:
Multiple Sclerosis Therapeutics market drug class outlook, by revenue (USD Million, 2012 - 2024)
·         Immunomodulators
·         Immunosuppressant
Multiple Sclerosis Therapeutics market mode of administration outlook, by revenue (USD Million, 2012 - 2024)
·         Injectable
·         Infused/Intravenous
·         Oral
Multiple Sclerosis Therapeutics market regional outlook, by revenue (USD Million, 2012 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Voice & Speech Recognition Software Market Projected To Be Worth $31.82 Billion By 2025

The global voice and speech recognition software market size is anticipated to reach USD 31.82 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 17.5% during the forecast period. The market is anticipated to witness an upsurge in the adoption of voice activated systems, voice-enabled devices, and voice-enabled virtual assistant systems owing to the rising application in the banking and automobile sectors. The escalating need to counter fraudulent activities and to enhance security in the banking sector is projected to boost the adoption of voice biometrics for user authentication.

Automobile sector is expected to gain momentum owing to advancements in technology and emergence of innovative concepts such as autonomous and connected cars. Integration of voice-activated software in future cars is anticipated to drive demand for technologies such as noise abatement for selectively ignoring driving and passenger noises for providing an error-free and seamless experience to the operator.
Voice recognition is also a core technology widely used in healthcare sector to enhance the Electronic Health Record (EHR) systems by providing an ease to the doctor to speak and keep the records instead of manual typing or writing. In 2018, the healthcare vertical held the largest market share and is expected to grow significantly over the forecast period.
Artificial Intelligence (AI)-based voice and speech recognition software is expected to expand at a high CAGR owing to the continuous development of machine learning techniques and integration of connected devices with personal assistants. For instance, Dragon Drive is a personal assistant developed by Nuance Communication Inc. that integrates various household appliances, cars, and smartphones that can be connected to a hub through the internet. Thus, an individual can get alerts about daily chores, work schedules, traffic updates, and many more alerts through the Dragon Drive.
However, the lack of accuracy of these technologies in recognizing the regional accents and dialects is expected to limit the growth of the voice and speech recognition software market. Additionally, sentiment analysis using the changes in the pitch of the voice is anticipated to provide growth opportunity to the market in the forthcoming years.
To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/voice-speech-recognition-software-market

Further key findings from the report suggest:
·       Rising trend in development of artificial intelligence-based system is expected to be the key factor driving the market over the forecast period. Leveraging deep learning algorithm in voice and speech solutions for better search results is expected to be the key growth driver for AI-based technology segment
·       Deployment of speech recognition solutions in consumer and retail verticals is anticipated to lead to the high market growth, attributed to the changing lifestyle in several countries including U.S., Germany, and U.K. Growing adoption of smart electronics in India, China, Japan, and Brazil is also likely to drive growth in consumer vertical
·       North America led the market, in terms of revenue, representing over 36% of the total market share in 2018. Additionally, North America and Asia Pacific are anticipated to witness a considerable growth owing to the presence of several U.S.- and China-based players, such as Apple, Inc.; Facebook, Inc.; Baidu, Inc.; Amazon.com, Inc.; and Alphabet, Inc.; working toward the development of this technology
·       Key companies operating in the voice and speech recognition software market include Advanced Voice Recognition Systems, Inc.; Agnitio S.L.; Amazon.com, Inc.; Api.ai; Apple, Inc.; Anhui USTC iFlytek o., Ltd.; Baidu, Inc.; BioTrust ID B.V.; CastleOS Software, LLC; Facebook, Inc.; Google, Inc.; International Business Machines Corporation; JStar; LumenVox LLC; M2SYSLLC; Microsoft Corporation; MModal, Inc.; Nortek Holdings, Inc.; Nuance Communications, Inc.; Raytheon Company; SemVox GmbH; Sensory, Inc.; ValidSoft UK Limited; VoiceBox Technologies Corporation; and VoiceVault, Inc. These players focus on integrating the artificial intelligence technology, to build superior products that would increase their user customer base.
Grand View Research has segmented the global voice and speech recognition software market report based on function, technology, vertical, and region.
Voice and Speech Recognition Software Function Outlook (Revenue, USD Million, 2014 - 2025)
·         Voice Recognition
o    Speaker Verification
o    Speech Recognition
·         Speaker Identification
o    Automatic Speech Recognition
o    Text to Speech
Voice and Speech Recognition Software Technology Outlook (Revenue, USD Million, 2014 - 2025)
·         AI-based
·         Non-AI based
Voice and Speech Recognition Software Vertical Outlook (Revenue, USD Million, 2014 - 2025)
·         Automotive
·         BFSI
·         Consumer
·         Education
·         Enterprise
·         Government
·         Healthcare
·         Legal
·         Military
·         Retail
·         Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
o    Mexico
·         Europe
o    Germany
o    U.K.
o    France
o    Italy
o    Spain
o    Netherlands
o    Switzerland
o    Poland
·         Asia Pacific
o    China
o    Japan
o    India
o    South Korea
o    Singapore
o    Pakistan
o    Malaysia
o    Australia
o    Hong Kong
o    Vietnam
·         South America
o    Brazil
o    Argentina
o    Chile
·         Middle East and Africa
o    UAE
o    Saudi Arabia
o    Israel
o    South Africa
o    Nigeria
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Patient Monitoring Accessories Market Poised to Expand at a Robust Pace Over 2033: Grand View Research Inc.

  Patient Monitoring Accessories Market Growth & Trends The global  patient monitoring accessories market  size is estimated to reach US...